Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 5, 2007, Pages 511-515

  Kulbersh, Brian D ^a   Duncan, Ryan D ^a   Magnuson, J Scott ^a   Skipper, Joni B ^a   Zinn, Kurt ^b   Rosenthal, Eben L ^a,c  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CETUXIMAB CY5.5 CONJUGATE; CONTRAST MEDIUM; FLUORESCENT DYE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE; HEAD AND NECK CANCER; HISTOLOGY; HISTOPATHOLOGY; LABORATORY DIAGNOSIS; MALE; MINIMAL RESIDUAL DISEASE; MOUSE; MOUTH; NONHUMAN; SENSITIVITY AND SPECIFICITY; STEREOMICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; EPIDERMAL GROWTH FACTOR; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MOUTH FLOOR; NEOPLASM, RESIDUAL; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TRANSPLANTATION, HETEROLOGOUS;

EID: 34249102871     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.5.511     Document Type: Article

References (18)

1. McMahon J, O'Brien CJ, Pathak I, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41:224-231.
2. Ravasz LA, Slootweg PJ, Hordijk GJ, Smit F, van der Tweel I. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg. 1991;19:314-318.
3. Mansfield JR, Gossage KW, Hoyt CC, Levenson RM. Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J Biomed Opt. 2005;10:41207.
4. Soltesz EG, Kim S, Kim SW, et al. Sentinel lymph node mapping of the gastro-intestinal tract by using invisible light. Ann Surg Oncol. 2006;13:386-396.
5. Parungo CP, Colson YL, Kim SW, et al. Sentinel lymph node mapping of the pleural space. Chest. 2005;127:1799-1804.
6. Spaulding DC, Spaulding BO. Epidermal growth factor receptor expression and measurement in solid tumors. Semin Oncol. 2002;29(suppl 14):45-54.
7. Bonner JA, De Los Santos J, Waksal HW, Needle MN, Trummel HQ, Raisch KP. Epidermal growth factor receptor as a therapeutic target in head and neck cancer. Semin Radiat Oncol. 2002;12(suppl 2):11-20.
8. Herbst RS, Kim ES, Harari PM. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer. Expert Opin Biol Ther. 2001;1:719-732.
9. Bonner JA, Raisch KP, Trummell HQ, et al. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers. J Clin Oncol. 2000;18(suppl):47S-53S.
10. Robert F, Ezekiel MP, Spencer SA, et al. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol. 2001;19:3234-3243.
11. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamouscell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578.
12. Rosenthal EL, Kulbersh BD, Duncan RD, et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope. 2006;116:1636-1641.
13. Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys. 2001;49:427-433.
14. Hsu ER, Anslyn EV, Dharmawardhane S, et al. A far-red fluorescent contrast agent to image epidermal growth factor receptor expression. Photochem Photobiol. 2004;79:272-279.
15. Ke S, Wen X, Gurfinkel M, et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 2003;63:7870-7875.
16. Gurfinkel M, Ke S, Wen X, Li C, Sevick-Muraca EM. Near-infrared fluorescence optical imaging and tomography. Dis Markers. 2003;19:107-121.
17. Parungo CP, Ohnishi S, De Grand AM, et al. In vivo optical imaging of pleural space drainage to lymph nodes of prognostic significance. Ann Surg Oncol. 2004;11:1085-1092.
18. Parungo CP, Ohnishi S, Kim SW, et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg. 2005;129:844-850.